Internal Medicine, Pulmonary Disease · Cleveland, TN
NPI
1043266752
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
110 Dunhill Pl NW
Cleveland, TN, 37311
Phone (423) 476-2212
Groups this clinician bills Medicare through
Medicare paid, 2024
$267K
4,222 services
Medicare patients, 2024
841
Average age 75
Drug cost, 2024
$3.7M
8,070 prescriptions
Company payments, 2025
$3,043
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ahmad M Ibrahimbacha was code 99214 (office e&m - established), 775 times for 466 patients. In total Ahmad M Ibrahimbacha billed 4,222 services in 37 codes, and Medicare paid $267K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 775 | 466 | $88.67 | $69K |
| 99232 Hospital E&M - Subsequent | Facility | 545 | 122 | $57.76 | $31K |
| 94010 Pulmonary Function Testing | Office | 417 | 339 | $18.52 | $7,722 |
| 99213 Office E&M - Established | Office | 366 | 276 | $61.15 | $22K |
| 99233 Hospital E&M - Subsequent | Facility | 345 | 135 | $86.47 | $30K |
| 71046 X-ray - Chest | Office | 278 | 249 | $23.00 | $6,394 |
| 94729 Pulmonary Function Testing | Office | 235 | 229 | $38.47 | $9,040 |
| 94726 Pulmonary Function Testing | Office | 224 | 217 | $37.83 | $8,473 |
| 99291 Critical Care E&M | Facility | 222 | 74 | $155.34 | $34K |
| 94664 E&M - Miscellaneous | Office | 114 | 106 | $12.20 | $1,391 |
| 94060 Pulmonary Function Testing | Office | 108 | 106 | $27.21 | $2,939 |
| 99223 Hospital E&M - Initial | Facility | 101 | 92 | $125.34 | $13K |
| 99205 Office E&M - New | Office | 54 | 54 | $154.20 | $8,327 |
| 94729 Pulmonary Function Testing | Facility | 46 | 44 | $6.39 | $294 |
| 94726 Pulmonary Function Testing | Facility | 46 | 44 | $8.64 | $398 |
By year: 2022 $281K for 4,765 services; 2023 $274K for 4,451 services; 2024 $267K for 4,222 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ahmad M Ibrahimbacha prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 1,836 prescriptions and refills. In total Ahmad M Ibrahimbacha wrote 8,070 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 1,836 | 2,094 | 330 | $1.3M |
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,483 | 1,652 | 420 | $45K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 584 | 633 | 118 | $391K |
| Prednisone Generic | 397 | 432 | 118 | $971 |
| Roflumilast Generic | 276 | 375 | 78 | $30K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 252 | 299 | 38 | $135K |
| Methylprednisolone Generic | 236 | 236 | 140 | $2,283 |
| Ventolin Hfa Albuterol Sulfate | 216 | 243 | 41 | $17K |
| Breo Ellipta Fluticasone/Vilanterol | 209 | 253 | 43 | $98K |
| Spiriva Respimat Tiotropium Bromide | 206 | 225 | 44 | $117K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 185 | 210 | 32 | $99K |
| Doxycycline Hyclate Generic | 183 | 183 | 129 | $1,032 |
| Montelukast Sodium Generic | 181 | 335 | 46 | $1,286 |
| Spiriva Handihaler Tiotropium Bromide | 177 | 210 | 42 | $106K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 95 | 122 | 24 | $13K |
Brand drugs: 5,032 claims; generic drugs: - claims; opioid claims: 46.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ahmad M Ibrahimbacha $3,043 ($3,043 in general payments such as food, travel and fees) from 22 companies. The largest payer was GlaxoSmithKline, LLC. with $461.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 24 | $461 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $371 |
| Verona Pharma, Inc. VRNA | 20 | $344 |
| Actelion Pharmaceuticals US, Inc. JNJ | 7 | $271 |
| Insmed, Inc. INSM | 13 | $269 |
| Genzyme Corporation SNY | 9 | $265 |
| Lilly USA, LLC LLY | 6 | $189 |
| Viatris Specialty LLC | 12 | $159 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $100 |
| Inspire Medical Systems, Inc. INSP | 4 | $89.9 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.